在免疫功能低下的儿童中确定甘西克洛维尔对细胞巨型病毒的治疗点
Wenyu Yang1, Adam Irwin2,3, Heather Weerdenburg4,5,6
1Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, Shanghai, China.
British journal of clinical pharmacology
|October 13, 2025
概括
建议血清甘西克洛维尔 (GCV) AUC24h目标为40-100 mg/L·h,用于治疗免疫受损儿童的细胞巨血病毒 (CMV). 免疫状态显著影响这种治疗点.
科学领域:
- 药理学 药理学是指药理学的学科.
- 病毒学 病毒学
- 儿科 儿科 儿科
背景情况:
- 甘西克洛维尔 (GCV) 对于治疗免疫功能低下儿童的细胞巨乳病毒 (CMV) 感染至关重要.
- 在儿科CMV治疗中,GCV的最佳治疗目标仍然不清楚,与成熟的成人目标不同.
研究的目的:
- 确定一种血清GCV治疗标 (AUC24h) 用于治疗免疫功能低下儿童的CMV病毒性病.
- 在这个人群中,将GCV暴露与病毒动态和治疗疗效相关联.
主要方法:
- 对14名儿童的GCV剂量,治疗药物监测和CMV病毒载荷的回顾性分析.
- 利用人口药理动力学模型和Emax建模来确定病毒动态和药物暴露效应.
- 根据免疫状态 (白细胞计数) 在药理动力学分析中进行调整.
主要成果:
- 确定了0.237 log10 副本/毫升/天的自然病毒复制率.
- 确定白细胞计数显著影响GCV的病毒衰减率.
- 90%的最大复制抑制和消除的GCV AUC24h目标估计分别为~40和~100 mg/L·h,WCC为3.7 × 10^9/L.
结论:
- 在儿科CMV治疗中,建议初步的血清GCV AUC24h目标范围为40-100 mg/L·h.
- 个体免疫状况是影响GCV治疗点的关键因素.
关键词:
这不是nonmemem.细胞巨型病毒 (cytomegalovirus) 是一种病毒.甘西克洛维尔 (ganciclovir) 是一种药物.儿科 儿科医生 儿科治疗目标是治疗的目标.病毒动态 病毒动态更多相关视频
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
17.7K
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
13.3K
相关概念视频
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
